SMYD3 and breast cancer: SMYD3 can upregulate WNT10B (an oncogene) expression while promoting epithelial–mesenchymal transition (EMT), thus facilitating the metastasis of BC (Hamamoto et al., 2006; Fenizia et al., 2019).